ORPEA : The underlying trend is to the upside
Entry price | Target | Stop-loss | Potential |
---|
€88.23 |
€95 |
€85 |
+7.67% |
---|
The timing appears opportune to go long in shares of Orpea as we anticipate another pick-up in the underlying trend.
Strengths● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 75.8 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 92.46.
● Technically, the stock approaches a strong medium-term resistance at EUR 87.92.
● One of the major weak points of the company is its financial situation.
● The company benefits from high valuations in earnings multiples.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.